Spain puts focus on early HIV detection:
This article was originally published in Clinica
Executive Summary
Early diagnosis of HIV infection is a key topic in the latest call for proposals by the Spanish foundation for AIDS research and prevention (FIPSE). This fourth round of projects is also likely to feature work on the epidemiological and clinical considerations surrounding coinfections involving HIV and hepatotropic viruses and tuberculosis. Proposals will be assessed according to scientific merit, relevance to the healthcare setting, viability and involvement of regional research institutions, the Spanish health ministry said last week. The ministry oversees the FIPSE. The deadline for the submission of proposals is February 28. Over the last three years, FIPSE (www.fipse.com) has funded 86 research projects, worth almost E8 million ($7.1million).
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.